ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), negative for estrogen receptor (ER), progesterone receptor (PR), and HER2, is the most aggressive subtype associated with poorer prognosis than other subtypes due to the lack of effective therapeutic targets [2].